Company: OCEA
Filing Date: 2025-02-14
Form Type: PRE 14A
Source: 0001493152-25-006994
Chunk: 58

Company: Ocean Biomedical, Inc.
Filing Date: 2025-02-14
Form: PRE 14A
Chunk 58
---
.oceanbiomedical.com.

OTHER MATTERS

The Company knows of no other matters to be submitted to the stockholders at the Annual Meeting, other than the proposals referred to in this Proxy Statement. If any other matters properly come before the stockholders at the Annual Meeting, it is the intention of the proxy holders to vote the shares represented thereby on such matters in accordance with their best judgment.

| By                               
 Order of the Board of Directors, |
| /s/                              
 Chirinjeev Kathuria              |
| Chirinjeev                       
 Kathuria                         |
| Chairman                         
 of the Board                     |
| January                          
 __, 2025                         |
| Providence,                      
 Rhode Island                     |

| 50 |

EXHIBIT 1

2024 Equity Incentive Plan

2025 EQUITY INCENTIVE PLAN

1. Purpose of the Plan. This 2025 Equity Incentive Plan (the “ Plan”) is intended as an incentive, to retain in the employ of and as directors, officers, consultants, advisors and employees to Ocean Biomedical, Inc. a Delaware corporation (the “ Company”), and any Subsidiary of the Company, within the meaning of Section 424(f) of the United States Internal Revenue Code of 1986, as amended (the “ Code”), persons of training, experience and ability, to attract new directors, officers, consultants, advisors and employees whose services are considered valuable, to encourage the sense of proprietorship and to stimulate the active interest of such persons in the development and financial success of the Company and its Subsidiaries.

It is further intended that certain options granted pursuant to the Plan shall constitute incentive stock options within the meaning of Section 422 of the Code (the “ Incentive Options”) while certain other options granted pursuant to the Plan shall be nonqualified stock options (the “ Nonqualified Options”). Incentive Options and Nonqualified Options are hereinafter referred to collectively as “ Options.”

The Company intends that the Plan meet the requirements of Rule 16b-3 (“ Rule 16b-3”) promulgated under the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), and that transactions of the type specified in subparagraphs (c) to (f) inclusive of Rule 16b-3 by officers and directors of the Company pursuant to the Plan will be exempt from the operation of Section 16(b) of the Exchange Act. Further, the Plan is intended to satisfy the performance-based compensation exception